Last reviewed · How we verify
NCT04259814
Effect of mCIMT Casting on Speech-language Outcomes in Children With Hemiparesis
NA trial testing Speech-language therapy (SLT) in Speech and Language Disorder in 3 participants. Completed in 26 May 2020.
26 May 2020
Quick facts
| Lead sponsor | Shirley Ryan AbilityLab |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 3 |
| Start date | 6 January 2020 |
| Primary completion | 26 May 2020 |
| Estimated completion | 26 May 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Speech-language therapy (SLT)
- Modified constraint-induced movement therapy (mCIMT)
Conditions studied
- Speech and Language Disorder — all drugs for Speech and Language Disorder →
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Hemiplegia — all drugs for Hemiplegia →
- Hemiparesis — all drugs for Hemiparesis →
Sponsor
Shirley Ryan AbilityLab — full company profile →
Who can join
Adults 15 Months to 7, any sex, with Speech and Language Disorder or Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Modified constraint-induced movement therapy (mCIMT) has been successfully used with children who have hemiplegia (weakness or paralysis on one side of the body.) mCIMT uses a removable cast during treatment and home exercise programs. It has been found that mCIMT can improve use, strength and coordination of a child's affected hand, and may also help improve speech and language skills. The goal of this project is to investigate whether combining mCIMT with speech therapy will enhance speech outcomes in children with cerebral palsy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04259814
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Speech and Language Disorder
Currently open trials in the same condition.
- NCT07460037 — Chinese-Specific Speech Imagery Coding Using High-Density ECoG · NA · recruiting
- NCT06512168 — Measuring Aided Language Development · NA · recruiting
- NCT05743439 — Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth · NA · recruiting
Other Shirley Ryan AbilityLab trials
Trials by the same sponsor.
- NCT07434492 — Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy · Phase 2 · not yet recruiting
- NCT07433023 — tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy · Phase 2 · not yet recruiting
- NCT06999213 — Lower Limb ExoNET: Development and Evaluation for Gait Assistance With Stroke Survivors · EARLY_PHASE1 · not yet recruiting
- NCT07032753 — Neuromusculoskeletal Interface for Bionic Arms · NA · not yet recruiting
- NCT07223710 — Improving Walking After Spinal Cord Injury · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04259814 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shirley Ryan AbilityLab
- Last refreshed: 21 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04259814.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing